China    manufacturer

Hangzhou AllTest Biotech CO.,LTD 

      Your Reliable Rapid Test Partner!

Sales & Support
Request A Quote - Email
Select Language
English
French
German
Italian
Russian
Spanish
Portuguese
Dutch
Greek
Japanese
Korean
Arabic
Turkish
China good quality Custom Monoclonal Antibody on sale China good quality Hybridoma Monoclonal Antibody on sale
I like the products and service provided by AllTest. They really take our interest into consideration.

—— Mr John Smith England

My oldest daughter actually has Lyme disease. She spent almost 1 year in a wheelchair because of Lyme. She is doing very well now. I used 2 of the samples. 1 to test my Lyme diagnosed daughter and 1 to test my daughter who does not have Lyme. Your tests worked well. My daughter with Lyme tested positive and the one who does not tested negative.

—— Ms Sheila

Whenever I have the requests,AllTest always give me the satisfied reply at the first time.

—— Mrs Julie Tschetter Belgium

I'm Online Chat Now

Oxazepam BZO Drug Abuse Test Kit One Step Cassette OEM ISO13485 / CE In Whole Blood /Serum/Plasma

Product Details:

Place of Origin:China
Brand Name:AllTest
Certification:CE, ISO13485
Model Number:Cassette(DBZ-402)

Payment & Shipping Terms:

Minimum Order Quantity:N/A
Price:Negotiation
Packaging Details:25 cassette/box
Delivery Time:2-4 Weeks
Payment Terms:Ex works
Supply Ability:10 M tests/month
Detailed Product Description
Format: Cassette Specimen: Whole Blood /Serum/Plasma
Kit Size: 40T/Kit Storage: 2-30℃
Color: White Certificate: CE


Oxazepam BZO Drug Abuse Test Kit One Step OEM  ISO13485 / CE In Whole Blood /Serum/Plasma

 

Applications:  

 

The BZO Rapid Test Cassette (whole blood/serum/plasma) is a lateral flow chromatographic immunoassay for the detection of Benzodiazepines in whole blood or serum or plasma at a cut-off concentration of 100ng/ml. This test will detect other related compounds, please refer to the
analytical Specificity table in this package insert.
This assay provides only a qualitative, preliminary analytical test result. A more specif ic alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical
consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used.

 

Description:  

 

The BZO One Step Benzodiazepines Test Device is an immunoassay based on the principle of competitive binding. Drugs that may be present in the urine specimen compete against the drug conjugate for binding sites on the antibody.

During testing, a urine specimen migrates upward by capillary action. BZO, if present in the urine specimen below cut-off concentration, will not saturate the binding sites of the anti-bodiesin the test device. The antibody coated particles will then be captured by immobilized benzodiazepine conjugate and a visible colored line will show up in the test line region. The colored line will not form in the test line region if the BZO level exceeds cut-off concentration, because it will saturate all the binding sites of anti-BZO antibodies.

A drug-positive urine specimen will not generate a colored line in the test line region because of drug competition, while a drug-negative urine specimen or a specimen containing a drug concentration lower than the cut-off will generate a line in the test line region because of the absence of drug competition.

To serve as a procedural control, a colored line will always appear at the control line region, indicating that proper volume of specimen has been added and membrane wicking has occurred.

 

How to use? 

 

Allow the test, specimen, buffer and/or controls to reach room temperature (15-30°C) prior to testing.
For serum or plasma specimen:
1. Bring the pouch to room temperature (15-30℃) before opening it. Remove the cassette from the sealed pouch and use it within one hour.
2. Place the cassette on a clean and level surface. Hold the dropper vertically and transfer 1 full drop of serum or plasma (approximately 40μl), then add 2 drops of buffer (approximately 80μl) to the specimen well of the cassette, and then start the timer. Avoid trapping air bubbles in the specimen well. See illustration below.
3. Wait for the colored line(s) to appear. Read the result at 5 minutes. Do not interpret the result after 10 minutes.
 

Oxazepam BZO Drug Abuse Test Kit One Step Cassette OEM ISO13485 / CE In Whole Blood /Serum/Plasma

For whole blood specimen:
1. Bring the pouch to room temperature before opening it. Remove the test cassette from the sealed pouch and use it as soon as possible.
2. Place the cassette on a clean and level surface.
For Venipuncture Whole Blood specimen:
 Hold the dropper vertically and transfer 1 drop of whole blood (approximately 40μl) to the specimen well, then add 2 drops of buffer (approximately 80μl), and start the timer. See illustration below.
For Fingerstick Whole Blood specimen:
 To use a capillary tube: Fill the capillary tube and transfer approximately 40μl of fingerstick whole blood specimen to the specimen area of test cassette, then add 2 drops of buffer(approximately 80μl) and start the timer. See illustration below.
3. Wait for the colored line(s) to appear. Read results at 5 minutes. Do not interpret the result after 10 minutes.

Oxazepam BZO Drug Abuse Test Kit One Step Cassette OEM ISO13485 / CE In Whole Blood /Serum/Plasma

 

INTERPRETATION OF RESULTS


(Please refer to the illustration above)


NEGATIVE:* Two lines appear. One colored line should be in the control line region (C), and another apparent colored line should be in the test line region (T). This negative result indicates that the Benzodiazepines concentration is below the detectable cut-off level.


*NOTE: The shade of color in the test line region (T) may vary, but it should be considered negative whenever there is even a faint colored line.


POSITIVE: One colored line appears in the control line region (C). No line appears in the test line region (T). This positive result indicates that the Benzodiazepines concentration exceeds the detectable cut-off level.


INVALID: Control line fails to appear. Insufficient specimen volume or incorrect procedural techniques are the most likely reasons for control line failure. Review the procedure and repeat the test with a new test. If the problem persists, discontinue using the test kit immediately and contact your local distributor.

 

 

.

Contact Details
Hangzhou AllTest Biotech CO.,LTD

Tel:86-571-56267891

Fax:86-571-56267856

Contact Person: Mrs. Selina

Send your inquiry directly to us (0 / 3000)